ArticleFrontiers in neuroanatomy2026
Postnatal expression of the transcription factor Ebf2 in motivation, reward, and pain-related circuits of the mouse brain.
Article in Frontiers in neuroanatomy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early B-cell factor 2 (Ebf2) is a transcription factor required for neuronal differentiation. However, its postnatal expression pattern and functional roles in the brain are not well characterized. This study examined the spatial distribution of Ebf2 in postnatal day 10 (P10) mouse brains and investigated its association with neural circuits mediating motivation, reward, and nociception. Materials and methods: Ebf2-TGFP transgenic mice, which express green fluorescent protein (GFP) as a reporter for Ebf2, were utilized. Immunofluorescence labeling and high-resolution microscopy were employed to visualize Ebf2 expression. Image data were analyzed using a deep learning-based segmentation pipeline for soma and axon identification. Three-dimensional reconstructions were registered to the Allen Brain Atlas. Quantitative comparisons between hemizygous and Ebf2-null mutant genotypes were conducted using linear mixed-effects models with Bonferroni and false discovery rate (FDR) corrections. Results: Ebf2 expression was prominent in the dorsal diencephalic conduction system, including the septum, habenula, and interpeduncular nucleus. Ebf2 expression can also be detected in the lateral hypothalamic area, zona incerta, ventral tegmental area, and parabrachial nucleus. Expression was also detected in nociceptive and sensory-motor regions such as the periaqueductal gray, anterior pretectal nucleus, principal sensory nucleus of the trigeminal nerve, and superior colliculus. Ebf2-null mutant mice showed a significant reduction in Ebf2-TGFP cells across most of these regions. Discussion: The results demonstrate that Ebf2 expression persists beyond embryonic development and is selectively enriched in neural circuits associated with motivation, reward processing, and nociceptive modulation. The marked reduction of Ebf2-TGFP expressing neurons in null mutants provides evidence for a postnatal requirement of Ebf2 in neuronal maintenance, rather than solely in early differentiation. Collectively, these findings broaden the functional scope of Ebf2 to include postnatal circuit stabilization and support its sustained regulatory role in brain systems that govern affective and pain-related behaviors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.